FLT3-ITD mutations play a crucial role in hematologic malignancies, impacting disease progression and treatment response. Identifying these mutations with high accuracy is essential for guiding targeted therapies and personalized treatment strategies.

The latest update to the HEMEaccuTest™ DNA pipeline and NGeneAnalySys™ v1.8.0.0 introduces advanced detection algorithms, significantly enhancing FLT3-ITD variant identification. With a 99.4% detection rate, this update vastly outperforms the previous 84.8% detection rate in v1.6.7.0, particularly for longer ITDs and those with low variant allele frequencies (VAFs).

Key Highlight:
✅ Improved ITD Detection – Increased sensitivity and specificity for critical FLT3-ITD mutations.

📥 Download the white paper now!